AKGÖR, U. Et Al. 2024. Impact of adjuvant treatments and risk factors on survival in 2023 FIGO stage IIB endometrial cancer patients: Turkish Gynecologic Oncology Group Study. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER .

AKGÖR, U., BAŞARAN, D., Meydanli, M. M., Kuscu, E., Demirkiran, F., TOPUZ, S., ... Sanci, M.(2024). Impact of adjuvant treatments and risk factors on survival in 2023 FIGO stage IIB endometrial cancer patients: Turkish Gynecologic Oncology Group Study. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER .

AKGÖR, UTKU Et Al. "Impact of adjuvant treatments and risk factors on survival in 2023 FIGO stage IIB endometrial cancer patients: Turkish Gynecologic Oncology Group Study," INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER , 2024

AKGÖR, UTKU Et Al. "Impact of adjuvant treatments and risk factors on survival in 2023 FIGO stage IIB endometrial cancer patients: Turkish Gynecologic Oncology Group Study." INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER , 2024

AKGÖR, U. Et Al. (2024) . "Impact of adjuvant treatments and risk factors on survival in 2023 FIGO stage IIB endometrial cancer patients: Turkish Gynecologic Oncology Group Study." INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER .

@article{article, author={UTKU AKGÖR Et Al. }, title={Impact of adjuvant treatments and risk factors on survival in 2023 FIGO stage IIB endometrial cancer patients: Turkish Gynecologic Oncology Group Study}, journal={INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER}, year=2024}